uniQure Announces First Clinical Data From Second Dose Cohort of AMT-060 in Ongoing Phase I/II trial in Patients with Severe Hemophilia B Nasdaq


https://globenewswire.com/news-release/2016/12/03/894861/0/en/uniQure-Announces-First-Clinical-Data-From-Second-Dose-Cohort-of-AMT-060-in-Ongoing-Phase-I-II-trial-in-Patients-with-Severe-Hemophilia-B.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s